Y-mAbs Therapeutics Appoints Peter Pfreundschuh As CFO, Effective June 28, 2024
Portfolio Pulse from Benzinga Newsdesk
Y-mAbs Therapeutics has appointed Peter Pfreundschuh as its new Chief Financial Officer, effective June 28, 2024. Pfreundschuh previously served as CFO at Voyager Therapeutics.
July 01, 2024 | 8:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Y-mAbs Therapeutics has appointed Peter Pfreundschuh as its new CFO, effective June 28, 2024. This leadership change could bring new strategic direction and financial oversight to the company.
The appointment of a new CFO often signals potential changes in financial strategy and corporate governance. Pfreundschuh's previous experience at Voyager Therapeutics may bring valuable insights and improvements to Y-mAbs Therapeutics.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100